Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study

Normalisation of eosinophil counts in sputum of asthmatic patients reduces eosinophilic exacerbations. However, the effect of this strategy on airway remodelling remains to be determined. We compared bronchial inflammation and collagen deposition after 2 yrs of treatment guided by either sputum eosinophils (sputum strategy, SS) or by clinical criteria (clinical strategy, CS). As a pilot study, 20 mild asthmatic patients were randomly assigned to CS or SS strategies. Bronchial biopsies were obtained when minimum treatment needed to maintain control was identified and this was continued for 2 yrs. Biopsies were immunostained for inflammatory cells, mucin 5A (MUC5A) and collagen. The mean dose of inhaled corticosteroids at the start and end of the study was similar in both SS and CS groups. Forced expiratory volume in 1 s increased in both groups at the study end. In SS, mucosal lymphocyte and eosinophil counts, but not neutrophils, were reduced at the end of the study. In CS, only activated eosinophil and neutrophil counts decreased. MUC5A staining decreased in SS but not CS. No change in collagen deposition underneath the basement membrane was observed in either strategy. Treatment strategies that normalise sputum eosinophils also reduce mucosal inflammatory cells and MUC5A expression, but do not change subepithelial collagen deposition in mild to moderate asthma.

[1]  Parameswaran Nair,et al.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.

[2]  F. Sériès,et al.  Tumor necrosis factor-alpha expression in uvular tissues differs between snorers and apneic patients. , 2008, Chest.

[3]  David J Erle,et al.  IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. , 2007, American journal of respiratory cell and molecular biology.

[4]  R. Leigh,et al.  Asthma as a disease concept , 2006, The Lancet.

[5]  A. Keech,et al.  Correction to the FIELD study report , 2006, The Lancet.

[6]  Q. Hamid,et al.  Mast cells regulate procollagen I (α1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4δ2 ratio , 2006 .

[7]  L. Boulet,et al.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.

[8]  Q. Hamid,et al.  Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio. , 2006, The Journal of allergy and clinical immunology.

[9]  D. Johns,et al.  Inter‐relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper‐reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  N. Wilson,et al.  Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. , 2005, American journal of respiratory and critical care medicine.

[11]  F. Sériès,et al.  Influence of weight and sleep apnea status on immunologic and structural features of the uvula. , 2004, American journal of respiratory and critical care medicine.

[12]  P. Jeffery,et al.  Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma , 2004, European Respiratory Journal.

[13]  J. Bousquet,et al.  Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[14]  L. Boulet,et al.  Adult Asthma Consensus Guidelines update 2003. , 2004, Canadian respiratory journal.

[15]  S. Holgate,et al.  Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. , 2003, American journal of respiratory and critical care medicine.

[16]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[17]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[18]  R. Hancox,et al.  Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship , 2002, European Respiratory Journal.

[19]  M. Bollinger.  Effect of Salmeterol on Allergen-Induced Airway Inflammation in Mild Allergic Asthma , 2002, Pediatrics.

[20]  L. Boulet,et al.  Bronchial inflammation in corticosteroid‐sensitive and corticosteroid‐resistant asthma at baseline and on oral corticosteroid treatment , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  D. Johns,et al.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma , 2002, Thorax.

[22]  L. Boulet,et al.  Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.

[23]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[24]  P. Sterk,et al.  Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. , 1999, American journal of respiratory and critical care medicine.

[25]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[26]  P. Sterk,et al.  Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  L. Boulet,et al.  Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[28]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.